BILLERICA, Mass.--(BUSINESS WIRE)--Bruker BioSciences Corporation (NASDAQ: BRKR) today announced that it has filed with the Securities and Exchange Commission its definitive proxy statement regarding the previously announced, planned acquisition of the Bruker BioSpin group of companies. A special meeting of Bruker BioSciences stockholders to consider and vote upon matters relating to the proposed acquisition will be held on February 25, 2008. Bruker BioSciences stockholders of record as of the close of business on January 11, 2008 will be entitled to vote at this special meeting.
